Financials

  • Market Capitalization 5.28 B
  • Employee 497
  • Founded 2011
  • CEO N/A
  • Website www.travere.com
  • Headquarter California, United States
  • FIGI BBG000P9D6W9
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-135.05
ratio cours/chiffre d'affaires
5.18

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
1252
BLTE
Belite Bio Inc - American Depositary Shares
148.77 USD+1.42%-2.32%+2.61%+135.73%5.85 B USD
1276
DNTH
Dianthus Therapeutics, Inc. - Common Stock
100.01 USD-1.25%+1.98%+21.21%+421.70%5.47 B USD
1345
DFTX
Definium Therapeutics, Inc. - Common Shares
45.69 USD-0.63%+0.86%+93.19%+202.38%4.98 B USD
1366
CRSP
CRISPR Therapeutics AG - Common Shares
51.37 USD+1.80%-13.23%-2.52%-3.87%4.95 B USD

Nouvelles